A Phase 1B Study Of RAD001 In Combination With Gemcitabine, Investigating Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Patients with Advanced Solid Tumours

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA Phase 1B Study Of RAD001 In Combination With Gemcitabine, Investigating Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Patients with Advanced Solid Tumours
StatusFinished
Effective start/end date1/11/02 → 31/12/06

Funding

  • NOVARTIS PHARMACEUTICALS UK LTD